The Development and Current Use of BCL-2 Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
Current Hematologic Malignancy Reports - United States
doi 10.1007/s11899-017-0359-0
Full Text
Open PDFAbstract
Available in full text
Date
January 23, 2017
Authors
Publisher
Springer Science and Business Media LLC